Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives
E Cavalli, A Bramanti, R Ciurleo… - International …, 2020 - spandidos-publications.com
The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a novel β
coronavirus that is the etiological agent of the pandemic coronavirus disease 2019 (COVID …
coronavirus that is the etiological agent of the pandemic coronavirus disease 2019 (COVID …
[HTML][HTML] A review of cardiac manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome with focus on endocarditis
MG Tayem, L Shahin, J Shook, MM Kesselman - Cureus, 2022 - ncbi.nlm.nih.gov
Patients with autoimmune diseases such as systemic lupus erythematosus (SLE) or
antiphospholipid syndrome (APS) are at a higher risk for adverse cardiovascular events …
antiphospholipid syndrome (APS) are at a higher risk for adverse cardiovascular events …
Antiphospholipid syndrome: state of the art of clinical management
L Depietri, MR Veropalumbo, MC Leone… - … Drugs and Therapy, 2023 - Springer
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically
characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the …
characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the …
Emerging therapies in antiphospholipid syndrome
The antiphospholipid syndrome (APS) is the most common cause of acquired immune-
mediated thrombophilia. This syndrome is broadly defined by the presence of arterial or …
mediated thrombophilia. This syndrome is broadly defined by the presence of arterial or …
Advances in management of the stroke etiology one-percenters
ND Osteraas, RM Dafer - Current Neurology and Neuroscience Reports, 2023 - Springer
Abstract Purpose of Review Uncommon causes of stroke merit specific attention; when
clinicians have less common etiologies of stoke in mind, the diagnosis may come more …
clinicians have less common etiologies of stoke in mind, the diagnosis may come more …
Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome
OC Kwon, YB Park, MC Park - Rheumatology, 2022 - academic.oup.com
Objective To assess the effect of statins on the prevention of recurrent thrombosis in patients
with thrombotic APS. Methods This retrospective cohort study included 184 patients with …
with thrombotic APS. Methods This retrospective cohort study included 184 patients with …
Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study
The aim of this study is to evaluate development of side effects, thrombotic or obstetric
complications in our antiphospholipid syndrome (APS) patient group, after vaccination …
complications in our antiphospholipid syndrome (APS) patient group, after vaccination …
Vitamin K Antagonist Reversal for Urgent Surgery Using 4-Factor Prothrombin Complex Concentrates: A Randomized Clinical Trial
R Sarode, JN Goldstein, G Simonian… - JAMA Network …, 2024 - jamanetwork.com
Importance Millions of people take vitamin K antagonists (VKAs). Some people who need
urgent surgical procedures require rapid VKA reversal to prevent excessive intraoperative …
urgent surgical procedures require rapid VKA reversal to prevent excessive intraoperative …
Successful treatment of catastrophic antiphospholipid syndrome using rituximab: case report and review of the literature
C Stanescu, AG Andronesi, C Jurcut, M Gherghiceanu… - Medicina, 2021 - mdpi.com
Background: Kidney involvement is a frequent complication of systemic lupus erythematosus
(SLE) and kidney biopsy is essential in differentiating lupus nephritis (LN) from thrombotic …
(SLE) and kidney biopsy is essential in differentiating lupus nephritis (LN) from thrombotic …
Management of patients with antiphospholipid antibodies: What to do in laboratory scenarios that do not fit the guidelines
G Pires Da Rosa, I Rodríguez-Pintó… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Some patients with positive antiphospholipid antibodies (aPL) have not been
included in randomized clinical trials or observational registries and, therefore, information …
included in randomized clinical trials or observational registries and, therefore, information …